SPHERE: Gastein Health Forum Research for the Citizens of Europe Science Europe Health Mark McCarthy Professor of Public Health University College London.

Slides:



Advertisements
Similar presentations
1 EU Strategy for the Baltic Sea Region as a tool to implement the EU2020 European Commission Directorate General Regional Policy Territorial Cooperation.
Advertisements

Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions.
Health and Wellbeing Angela Hamilton Policy and Information Officer Newcastle City Council.
South Africa’s S&T partnership with the European Union From FP4 to Horizon 2020 Daan du Toit Senior S&T Representative to the EU.
School of something FACULTY OF OTHER Centre for Disability Studies European Research Agendas for Disability Equality (EuRADE)
Izolda Bulvinaite, European Commission ,DG MARE, E1
1 Retinopathy in Europe How can we make further progress? What can the European Union do? Christoph STEFFEN, DG INFSO, European Commission
European Heart Health Charter Official Launch 12 June 2007 European Parliament - Brussels "Every child born in the new millennium has the right to live.
Towards the Global Markets Merja Heikela Senior Consultant, Finpro UK-Benelux.
Intelligence Unit 6 - Mandates for Action Policy exerts a powerful influence on public health nutrition (PHN) practice because it affects:  service delivery.
Influencing Health Care Policy
The Dutch R&D system characteristics and trends, with a focus on government funding Jan van Steen Ministry of Education, Culture and Science, The Netherlands.
Food security and nutrition challenges at global and regional level Mark Smulders Senior Economist Agricultural Development Economics Division FAO, Rome.
SPHERE: EPHA Extraordinary General Assembly SPHERE Strengthening Public Health Research in Europe Science Europe Health Gabrielle Harvey Mark.
1 Science and Society: EU Strategy and actions Dr. Rainer GEROLD Director Science and Society Research DG European Commission.
REGIONAL REPRESENTATION IN BRUSSELS Securing effective working on the European Agenda Jeremy Howell Economic Development and European Policy Consultant.
The involvement of patients in Health Technology Assessment Andrzej Rys Director Health and Consumers Directorate-General Brussels 18 May 2010.
CEI Consultation on the European Technology Platform Food for Life: Optimising regional benefit Dr Kitti Németh VUP Food Research Institute, Bratislava,
January THE ISSUE Launch Event. Leicester. THE ISSUE Traffic- Health- Environment. Intelligent Solutions Sustaining Urban Economies. Professor.
European Health Forum Gastein, Bad Hofgastein, Austria, September 2002 The Sixth Framework Programme and Policy Support Research – “Priority 8” Parallel.
World Health Organization Department of Chronic Diseases and Health Promotion World Health Organization Global Perspective on Health Promotion Tang Kwok-cho.
PUBLIC HEALTH WORKFORCE LINCOLNSHIRE GOVERNMENT Isabel Perez, Consultant in Public Health 17 th June 2014.
DEVCO Approach Paper Research & Innovation for Food and Nutrition Security / Sustainable Agriculture.
Session Chair: Peter Doorn Director, Data Archiving and Networked Services (DANS), The Netherlands.
EPHA Presentation EPHA, the EU and Health. EPHA Presentation European Public Health Alliance A network of more that 100 non governmental and not-for-profit.
DETERMINE an EU Consortium for Action on the socio-economic determinants of health Dorothee Heinen Federal Centre for Health Education, BZgA Reducing Health.
Historical development ICC-TB recommends creating a Partnership in meeting, Sept 2004 WHO signed co-funding agreement with Federation Red Cross, Aug 2006.
Introducing the ITF. International Affiliation  Our union is affiliated to the International Transport Workers’ Federation (ITF).  Many members do not.
Elizabeth Docteur European Health Forum Gastein 7 October 2004 Towards High-Performing Health Systems: Challenges and Opportunities for Reform.
Internationalisation of Finnish Public Research Organisations Dr. Antti Pelkonen Senior Scientist, VTT Technical Research Centre of Finland
1 SMEs – a priority for FP6 Barend Verachtert DG Research Unit B3 - Research and SMEs.
Patient Information Forum (PiF) Overview.
Health challenges in an enlarged Europe Report from Parallel Session A1 Dr. Natasha Azzopardi Muscat Ministry of Health - Malta.
Dublin, 1 November 2012 Challenges and Opportunities in Europe Monika Kosinska Secretary General European Public Health Alliance.
Public health research in Europe Mark McCarthy (University College London) Levels of health sciences molecules cells organs people populations Laboratory.
Improving health and tackling inequalities through Partnership Trish Crowson Platform Director Hosted by.
Policy Research and Innovation Research and Innovation Enhancing and focusing EU international cooperation in research and innovation: A strategic approach.
The Experience of a Leader in Innovation. The Case of Finland Professor Reijo Vihko President and Director General The Academy of Finland.
DETERMINE Working document # 4 'Economic arguments for addressing social determinants of health inequalities' December 2009 Owen Metcalfe & Teresa Lavin.
The Politics of Reform Processes Gem Arwings-Kodhek, ACSU, Kenya Future Agricultures Consortium Workshop on Politics and Policy Processes for the 2008.
FP7 /1 EUROPEAN COMMISSION - DG Research Nikos Kastrinos Directorate for Research in Social Sciences, Humanities and Foresight of DG Research, European.
 Civil Society is understood to encompass all associations formal and informal that are outside the state and the private market sector. They are associations,
Results Focus is Focusing on the Solution: SHIFTING FROM AID THAT WORKS TO DEVELOPMENT THAT WORKS Richard Ssewakiryanga Executive Director Uganda National.
A STRONG PATIENTS’ VOICE TO DRIVE BETTER HEALTH IN EUROPE EPF Annual General Meeting 19 May 2010 EPF Annual General Meeting 19 May 2010.
E u r o p e a n C o m m i s s i o nCommunity Research Global Change and Ecosystems EU environmental research : Part B Policy objectives  Lisbon strategy.
HOW TO MAKE RESEARCH MEANINGFUL TO POLICY MAKERS: THE VALUE OF A LOBBYING STRATEGY Toby Aykroyd.
1 EUROPEAN INNOVATION POLICY: Innovation policy: updating the Union’s approach in the context of the Lisbon strategy Thursday, 9 October 2003 Sofia, Bulgaria.
Technology Platform “Plants for the Future” Member State Consultations on the Stakeholders Proposal for a Strategic Research Agenda
ELEMENTS OF STRATEGY FOR ACHIEVING SOCIAL PROTECTION FLOOR Global Network, Cape Town 7 December 2012 BY AFRICAN LABOUR RESEARCH NETWORK (ALRN)
ROAD MAP FOR E2S RESEARCH. MAPPING E2S RESEARCH WHAT HAS BEEN DONE GAPS WHO IS DOING WHAT.
EACP European Aerospace Cluster Partnership ESCP Partners:
MUNROS is funded by the European Commission FP7 programme MUNROS is funded by the European Commission FP7 programme,
EHFG 7 October 2005 – Patient Safety & Research UK Presidency Workshop on Patient Safety, EHFG, Bad Hofgastein,7 September 2005 Kevin McCarthy, European.
Delivering Regeneration in a New Context Stephen White Housing and Regeneration Directorate 27 August 2009.
2 nd October 2009 John B Scicluna Manager - Sectors.
EU-China: : Demonstrating Smart Cities achievements Dr Shaun Topham EU eForum.
Practical Aspects of Preparation FP 6 projects Senter/EG-Liaison Nationaal Contact Punt voor het 6de Kaderprogramma Sandra de Wild 11 december 2002.
IPP Network Meeting London, 7-8 November 2005 A report of the discussions Bob Ryder Department for Environment, Food & Rural Affairs (UK)
South Africa – European Union Science and Technology Cooperation Brussels 30 January 2006.
June 13, BRIEF NOTES ON METEOROLOGICAL ACTIVITIES AT THE EAST AFRICAN COMMUNITY PRESENTATION BY JOHN MUNGAI SENIOR METEOROLOGIST EAC.
Richard Escritt, Director – Coordination of Community Actions DG Research, European Commission “The development of the ERA: Experiences from FP6 and reflections.
Social Sciences and Humanities in Europe: New Challenges, New Opportunities “The influence of the Framework Programmes in Social Sciences and Humanities.
"Innovation-based Growth – the Development and the Future Challenges of the Finnish Innovation Environment” Timo Kekkonen Director, Confederation of Finnish.
Richard Murrugarra – Centurion
European (Sector) Social Dialogue overview & update
3b. The Foundations of HiAP
Maximizing the value and the impact of health research in Europe
27 November 2014 Mantas Sekmokas
Follow us: June 15-16, 2017 Steering Committee Meeting Summary of Conclusions and Action Items Follow.
New Services for Ageing Well in the Information Society
Presentation transcript:

SPHERE: Gastein Health Forum Research for the Citizens of Europe Science Europe Health Mark McCarthy Professor of Public Health University College London

A thought experiment The European Director General for Health, a fit, handsome man, defines obesity as a key issue for European health policy --- And so …

SPHERE: Gastein Health Forum What evidence? Laboratory – overfeeding kills rats Laboratory – overfeeding kills rats Human – obesity reduces the lifespan Human – obesity reduces the lifespan Economic – affluence leads to indulgence Economic – affluence leads to indulgence Environment – people don’t exercise enough Environment – people don’t exercise enough Working with WHO, an expert committee concurs ‘from the evidence, this is a key health issue.’

SPHERE: Gastein Health Forum But what is to be done? Determinants of obesity include Determinants of obesity include food, built environment, transport, health system Impacts of obesity are: Impacts of obesity are: diseases – heart, diabetes, arthritis, health care system – surgery, utilisation, cost Politics of obesity include: Politics of obesity include: regulatory (eg labelling), economic (eg regeneration), trade & private sector (eg road lobby)

SPHERE: Gastein Health Forum Research questions What interventions? What interventions? Under what circumstances? Under what circumstances? Will achieve what effects? Will achieve what effects? Over what period? Over what period? At what cost? At what cost?

SPHERE: Gastein Health Forum Let’s use the literature Mostly from USA Mostly from USA European literature - local languages? European literature - local languages? Studies not designed as interventions Studies not designed as interventions Studies not coordinated across cultures Studies not coordinated across cultures Replication difficult and not rewarded Replication difficult and not rewarded

SPHERE: Gastein Health Forum Can we mobilise European research? DG Health - limited research budget DG Health - limited research budget DG Research - limited calls for health policy in FP6 DG Research - limited calls for health policy in FP6 o biomedicine directed towards ‘genomics’ o disease dominated by cancer o and environment, food, transport, informatics - all have their own agendas

SPHERE: Gastein Health Forum Member states … ‘Let’s leave health research to our profitable pharmaceutical industry’ ‘Let’s leave health research to our profitable pharmaceutical industry’ ‘Why pay for research if others don’t?’ ‘Why pay for research if others don’t?’ ‘Will the results conflict with domestic policies?’ ‘Will the results conflict with domestic policies?’ ‘Other European countries don’t have domestic political impact’ ‘Other European countries don’t have domestic political impact’

SPHERE: Gastein Health Forum Looking westwards Task Force on Obesity Task Force on Obesity DHHS pays for NIH, AHQR, CDC DHHS pays for NIH, AHQR, CDC Research linked to project interventions (both funded) Research linked to project interventions (both funded) Multidisciplinary – laboratory, environment, economics, modelling, observational, sociology, health promotion … Multidisciplinary – laboratory, environment, economics, modelling, observational, sociology, health promotion …

SPHERE: Gastein Health Forum Another thought experiment A bold, handsome Prime Minister decides that public services should be privatised, and health care is an excellent market opportunity A bold, handsome Prime Minister decides that public services should be privatised, and health care is an excellent market opportunity What is the evidence – ? What is the evidence – ?

SPHERE: Gastein Health Forum Public health research Influence policies Influence policies Knowledge from practice Knowledge from practice Good designs, strong comparisons Good designs, strong comparisons Multiple disciplines Multiple disciplines Multiple partners Multiple partners

SPHERE: Gastein Health Forum Public health research organisations Not disease causation – even inequalities – but interventions Not disease causation – even inequalities – but interventions Require special support to understand MS differences Require special support to understand MS differences Capable of competition but also require foundations Capable of competition but also require foundations Public sector must engage where pharma doesn’t Public sector must engage where pharma doesn’t

SPHERE: Gastein Health Forum SPHERE Discussion of FP6 Discussion of FP6 A call - ‘support action for FP7’ A call - ‘support action for FP7’ Engaging partners Engaging partners Creating structures - a European Research Market needs organisation and players Creating structures - a European Research Market needs organisation and players

SPHERE: Gastein Health Forum SPHERE Strengthening Public Health Research in Europe Science Europe Health